 The development of serotype-specific anticapsular monoclonal antibodies has also been researched in recent years.These antibodies have been shown to prolong survival in a mouse model of pneumococcal infection characterized by a reduction in bacterial loads and a suppression of the host inflammatory response.Additional pneumococcal vaccine research is taking place to find a vaccine that offers broad protection against pneumococcal disease.